Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Naprosyn E
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the uptake in the body of naproxen; one of the two
active substances in PN400. We also want to show that the body's uptake of naproxen given as
PN400 is comparable to that of currently marketed naproxen tablets.